RNAi Therapeutics Market Research Report 2021-2031
2021 年 RNAi 治疗市场估值为 15 亿美元,预计到 2031 年将达到 32 亿美元。预计 2023 年至 2031 年该市场的复合年增长率为 16.5%。不断增加的研发 (R&D) 活动可能仍然是 RNAi 治疗市场的主要趋势。
RNAi治疗市场分析
RNAi 疗法在癌症治疗中的应用
RNAi 技术是一种新的癌症治疗方式,有几种候选技术正在接受临床测试。 RNAi用于癌症治疗的显着优势是其高特异性,可用于癌症治疗的基因有无限的选择。例如,RNAi疗法可以干扰血管生成、转移、肿瘤的化疗耐药性和癌细胞的增殖。此外,10种基于RNAi的癌症疗法已进入早期临床试验,展示了具有特定基因沉默功效的RNAi在癌症治疗中的潜在能力。因此,上述因素对 2021-2031 年 RNAi 治疗市场的增长具有影响力。
RNAi 治疗市场概述
技术、创新和智能技术解决方案等继续对 RNAi 疗法产生重大影响。癌症治疗中的 RNAi 疗法和不断增加的开发创新 RNAi 疗法的临床试验是 RNAi 治疗市场增长的最有影响力的因素。不断增加的研发 (R&D) 活动是 RNAi 治疗市场增长的关键趋势。 RNAi 疗法的成像方式将提供利润丰厚的市场机会。
定制研究以满足您的要求
我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
RNAi 治疗市场:
年均复合增长率(2023 - 2031)16.5%- 2021 年市场规模
15 亿美元 - 2031 年市场规模
32 亿美元
市场动态
- RNAi 疗法在癌症治疗中的应用 Therapeutics in Cancer Therapy
- 研发 (R&D) 活动不断增加
- RNAi 治疗的成像方式 RNAi 治疗RNAi Therapeutics for RNAi Therapeutics
关键人物;主力;重要一员
- Alnylam 制药公司, Pharmaceuticals, Inc.,
- 赛诺菲,
- 奥利克斯制药公司,
- 葛兰素史克公司,
- 贝尼泰克生物制药,
- 杨梅生物制药公司,
- 沉默疗法,
- 雷克森制药公司,
- 箭头制药公司,
- 夸克,
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 小干扰RNA
- 遗传性疾病
- 肿瘤学
- 神经退行性疾病
- 心血管
- 呼吸系统疾病
- 传染性疾病
- 肾脏疾病
- 其他的
- 皮内注射
- 肺部输送
- 静脉注射
- 腹腔注射
- 其他的
- 诊断实验室
- 研究与学术实验室
- 医院
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
RNAi 治疗市场驱动因素和机遇
开发创新 RNAi 疗法的临床试验不断增加,有利于市场
- 2023年8月,Sirnaomics宣布“STP707”RNAi疗法临床1期,该疗法显示出治疗转移性肿瘤的良好临床潜力。该临床研究在美国进行,多个领先癌症中心参与,包括梅奥诊所肿瘤中心、埃默里癌症中心、南加州大学/霍格分校和耶鲁大学癌症中心。
- 此外,Alnylam 公司拥有强大的研究性 RNAi 疗法产品线,可满足治疗选择有限或不充分的疾病患者的需求,这些疾病包括:遗传药物、心脏代谢疾病、传染病、中枢神经系统 (CNS) 和眼部疾病。产品包括“ONPATTRO”、“AMVUTTRA”、“GLVLAARI”、“OXLUMO”、“Leqvio”、“Vutrisiran”、“Fitusiran”、“Cemdisiran”、“Zilebrsiran”、“ALN-HSD”、“Elebsiran”、“贝尔塞西兰”、“ALN-APP”、“ALN-TTRsc04”、“ALN-APP”、“ALN-KHK”、“ALN-BCAT”、“ALN-PNP”。
因此,越来越多的 RNAi 疗法临床试验将在未来几年做出重大贡献。
RNAi 治疗成像模式对 RNAi 治疗市场的机遇
目前,多种分子成像模式已应用于RNAi相关研究,例如光学成像(荧光和生物发光)、磁共振成像(MRI)、磁共振波谱(MRS)、SPECT和正电子发射断层扫描(PET)。此外,RNAi治疗效果的分子成像仍处于临床前阶段,重点是活体动物中标记基因表达水平的可视化。这些成像标记物大多是生物发光酶,可以准确测量其药理活性。此外,MRS 还被证明可用于评估基于 RNAi 的疗法的疗效,因为它具有直接检测生物学结果的潜力。此外,在测量某些化合物(例如胆碱)的化学位移方面,MRS 的功能比光学成像更好,这些化合物在组织或肿瘤中的浓度可以通过某些治疗干预来改变。因此,研发活动为 RNAi 治疗市场提供了利润丰厚的市场机会,在未来几年占据相当大的市场份额。
RNAi疗法
市场报告细分分析
有助于 RNAi 治疗市场分析的关键部分是候选资格和服务。
- 根据分子类型,RNAi 治疗市场分为小干扰 RNA (siRNA) 和 MicroRNA (miRNA)。小干扰RNA(siRNA)可能会在2023年占据更大的市场份额。
- 根据应用,RNAi 治疗市场分为遗传性疾病、肿瘤、神经退行性疾病、心血管、呼吸系统疾病、传染病、肾脏疾病等。到2023年,肿瘤学可能会占据更大的市场份额。
- 根据给药途径,RNAi 治疗市场分为皮内注射、肺部给药、静脉注射、腹膜内注射等。 2023年,肺输送可能会占据更大的市场份额。
- 根据最终用户,RNAi 治疗市场分为诊断实验室、研究和学术实验室以及医院。到 2023 年,研究和学术实验室可能会占据更大的市场份额。
按地域划分的 RNAi 治疗市场份额分析
RNAi TherapeuticsMarket报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲/南美洲和中美洲。
北美主导了 RNAi 治疗市场。在北美,美国在 RNAi 治疗领域占据相当大的份额。美国顶尖医疗生物技术和制药公司的存在。此外,加强研发(R&D)活动的合同研究组织(CRO)的存在是对市场增长最有影响力的因素之一。预计亚太地区未来几年将以最高的复合年增长率增长。
RNAi疗法
市场报告范围
报告属性 | 细节 |
---|---|
2021年市场规模 | 15亿美元 |
2031 年市场规模 | 32亿美元 |
全球复合年增长率(2023 - 2031) | 16.5% |
历史数据 | 2021-2022 |
预测期 | 2023-2031 |
涵盖的细分市场 | 按分子类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
RNAi 治疗市场新闻和最新动态
RNAi 治疗市场是通过收集初级和二级研究后的定性和定量数据进行评估的,其中包括重要的公司出版物、协会数据和数据库。以下是 RNAi 治疗市场的发展和策略:
- 2024 年 4 月,诺华宣布在现实环境中推出“Leqvio”,用于最大耐受他汀类药物治疗,先于指南推荐的依折麦布,从而降低动脉粥样硬化性心血管疾病患者的低密度脂蛋白胆固醇 (LDL-C) (ASCVD)。
RNAi 治疗市场报告范围和交付成果
《RNAi 治疗市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:
- 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
- 市场动态,例如驱动因素、限制因素和关键机遇
- 未来主要趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
- 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
- 详细的公司简介
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.